Rituximab (RTX) has showed efficacy and safety in the treatment of primary membranous nephropathy (PMN). Inhere, We present a case of primary membranous GN that recovered completely with no relapse after Rituximab therapy and did not require steroid therapy.
No takes yet. Share an insight, caveat, or question.
Akl et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: